Get App Open
In App
News on WhatsApp
News on WhatsApp
Open App

Ind-Swift Ltd.

BSE: 524652 | NSE: INDSWFTLTD | Series: NA | ISIN: INE788B01028 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Aug 13, 16:01
15.70 0.00 (0.00%)
Volume
AVERAGE VOLUME
5-Day
29,095
10-Day
17,213
30-Day
25,266
0
  • Prev. Close

    15.70

  • Open Price

    14.86

  • Bid Price (Qty.)

    15.60 (10)

  • Offer Price (Qty.)

    15.80 (200)

Ind-Swift is not traded on BSE in the last 30 days

NSE Live

Aug 13, 15:46
15.76 0.00 (0.00%)
Volume
AVERAGE VOLUME
5-Day
168,605
10-Day
105,520
30-Day
186,694
0
  • Prev. Close

    15.76

  • Open Price

    15.16

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

Ind-Swift is not traded on NSE in the last 30 days

Financials

Profit & Loss account of Ind-Swift (in Rs. Cr.) Mar 25 Mar 24 Mar 23 Mar 22 Mar 18  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 515.23 492.53 398.89 391.30 270.57  
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 0.00 0.00 0.00  
Revenue From Operations [Net] 515.23 492.53 398.89 391.30 270.57  
Total Operating Revenues 515.23 502.25 410.96 397.71 270.57  
Other Income 47.62 57.99 11.85 23.55 10.16  
Total Revenue 562.85 560.24 422.81 421.26 280.73  
EXPENSES  
Cost Of Materials Consumed 224.56 206.50 194.97 192.28 125.35  
Purchase Of Stock-In Trade 45.98 44.83 38.50 20.15 36.89  
Operating And Direct Expenses 0.00 25.33 23.85 25.07 0.00  
Changes In Inventories Of FGWIP And Stock In Trade -10.36 29.85 -15.43 -1.41 -8.09  
Employee Benefit Expenses 91.81 78.32 69.15 63.15 48.27  
Finance Costs 39.16 62.94 59.76 57.16 7.05  
Depreciation And Amortisation Expenses 23.50 27.11 28.67 32.07 34.63  
Other Expenses 140.26 68.92 57.89 53.12 61.85  
Total Expenses 554.91 543.78 457.35 441.60 305.96  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 7.94 16.46 -34.54 -20.34 -25.23  
Exceptional Items 279.97 0.00 60.58 0.73 -28.15  
Profit/Loss Before Tax 287.91 16.46 26.04 -19.60 -53.38  
Tax Expenses-Continued Operations  
Current Tax 4.46 0.00 0.00 0.00 0.00  
Less: MAT Credit Entitlement 0.00 -2.27 0.00 0.00 0.00  
Deferred Tax 0.00 0.00 0.00 0.00 0.00  
Other Direct Taxes 0.00 0.00 0.00 0.00 0.00  
Total Tax Expenses 4.46 2.23 0.00 0.42 0.75  
Profit/Loss After Tax And Before ExtraOrdinary Items 283.45 14.23 26.04 -20.02 -54.13  
Profit/Loss From Continuing Operations 283.45 14.23 26.04 -20.02 -54.13  
Profit/Loss For The Period 283.45 14.23 26.04 -20.02 -54.13  
Minority Interest 0.00 0.00 0.00 0.00 0.00  
Consolidated Profit/Loss After MI And Associates 283.45 14.23 26.04 -20.02 -50.43  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 52.00 3.00 5.00 -4.00 -9.00  
Diluted EPS (Rs.) 52.00 3.00 5.00 -4.00 -9.00  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 0.00 0.00 0.00 0.00 0.00  
Tax On Dividend 0.00 0.00 0.00 0.00 0.00  
Source : Dion Global Solutions Limited

Results of Pharmaceuticals Sector

Advisory Alert:

It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347